BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 17579892)

  • 1. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
    Power KA; Thompson LU
    Mol Nutr Food Res; 2007 Jul; 51(7):845-56. PubMed ID: 17579892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
    Power KA; Ward WE; Chen JM; Saarinen NM; Thompson LU
    Bone; 2006 Jul; 39(1):117-24. PubMed ID: 16469549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada.
    Boucher BA; Cotterchio M; Curca IA; Kreiger N; Harris SA; Kirsh VA; Goodwin PJ
    Nutr Cancer; 2012; 64(5):695-703. PubMed ID: 22642930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice.
    Penttinen-Damdimopoulou PE; Power KA; Hurmerinta TT; Nurmi T; van der Saag PT; Mäkelä SI
    Mol Nutr Food Res; 2009 Aug; 53(8):996-1006. PubMed ID: 19603405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of dietary phytoestrogens in chronic renal disease.
    Ranich T; Bhathena SJ; Velasquez MT
    J Ren Nutr; 2001 Oct; 11(4):183-93. PubMed ID: 11679998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
    Hutchins AM; Slavin JL; Lampe JW
    J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo.
    Bergman Jungeström M; Thompson LU; Dabrosin C
    Clin Cancer Res; 2007 Feb; 13(3):1061-7. PubMed ID: 17289903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
    Messina M; McCaskill-Stevens W; Lampe JW
    J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts.
    Saarinen NM; Power K; Chen J; Thompson LU
    Int J Cancer; 2006 Aug; 119(4):925-31. PubMed ID: 16557589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early life and adult exposure to isoflavones and breast cancer risk.
    Tomar RS; Shiao R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):113-73. PubMed ID: 18569328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
    Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of phytoestrogen intake for breast cancer.
    Duffy C; Perez K; Partridge A
    CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.
    Allred CD; Twaddle NC; Allred KF; Goeppinger TS; Churchwell MI; Ju YH; Helferich WG; Doerge DR
    J Agric Food Chem; 2005 Nov; 53(22):8542-50. PubMed ID: 16248551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice.
    Truan JS; Chen JM; Thompson LU
    Nutr Cancer; 2012; 64(1):65-71. PubMed ID: 22136581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy consumption alters endogenous estrogen metabolism in postmenopausal women.
    Xu X; Duncan AM; Wangen KE; Kurzer MS
    Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):781-6. PubMed ID: 10952094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.
    Messina M; Hilakivi-Clarke L
    Nutr Cancer; 2009; 61(6):792-8. PubMed ID: 20155618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
    Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
    Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.